Previous close | 5.20 |
Open | N/A |
Bid | 3.70 |
Ask | 7.40 |
Strike | 170.00 |
Expiry date | 2025-01-17 |
Day's range | 5.20 - 5.20 |
Contract range | N/A |
Volume | |
Open interest | 5 |
On May 10, 2024, Joseph Laplume, Executive Vice President of Corporate Strategy & Development, sold 1,304 shares of Charles River Laboratories International Inc (NYSE:CRL).
Explore Charles River's (CRL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.